This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Orchid Ventures Past Earnings Performance
Past criteria checks 0/6
Key information
-6.9%
Earnings growth rate
51.5%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | -2.0% |
| Return on equity | n/a |
| Net Margin | -236.4% |
| Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Orchid Ventures makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 22 | 1 | -3 | 4 | 0 |
| 31 Dec 21 | 2 | -4 | 4 | 0 |
| 30 Sep 21 | 2 | -3 | 4 | 0 |
| 30 Jun 21 | 4 | -3 | 4 | 0 |
| 31 Mar 21 | 3 | -3 | 3 | 0 |
| 31 Dec 20 | 4 | -2 | 3 | 0 |
| 30 Sep 20 | 3 | -4 | 4 | 0 |
| 30 Jun 20 | 1 | -7 | 5 | 0 |
| 29 Feb 20 | 4 | -10 | 8 | 0 |
| 30 Nov 19 | 5 | -11 | 9 | 0 |
| 31 Aug 19 | 5 | -9 | 8 | 0 |
| 31 May 19 | 6 | -7 | 7 | 0 |
| 28 Feb 19 | 4 | -2 | 4 | 0 |
| 30 Nov 18 | 3 | -2 | 4 | 0 |
| 31 Aug 18 | 3 | -1 | 3 | 0 |
| 31 May 18 | 2 | -2 | 3 | 0 |
Quality Earnings: ORCD is currently unprofitable.
Growing Profit Margin: ORCD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ORCD is unprofitable, and losses have increased over the past 5 years at a rate of 6.9% per year.
Accelerating Growth: Unable to compare ORCD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ORCD is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (17.8%).
Return on Equity
High ROE: ORCD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.